MabCure, Inc. Aktie
MBCI
$0.0005+0.0003 (+150.00%)
Chart wird geladen...
MabCure, Inc.
Market Cap
$390
Eröffnung0.0001
Hoch0.0001
Tief0.0001
Volumen100
P/EN/A
Marktkapitalisierung390
52-Wochen-Hoch0.0005
52-Wochen-Tief0.0000
Durchschn. Volumen893
DividendeN/A
Beta9.41
EPS-0.0300
Über MabCure, Inc. Aktie
MabCure, Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure, Inc. in January 2008 to reflect its new business plan. MabCure, Inc. was founded in 2006 and is based in White Plains, New York.
Unternehmensinformationen
Börse: OTC Markets OTCPK (PNK)
Sektor: Teknologi
Branche: Solenergi
Adresse:
21 Sparrow Circle
10605 White Plains, United States
10605 White Plains, United States
Telefon: + 845 591 3144
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.
Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel